NIHR Clinical Lecturer in General Practice
Tel: 01223 769294
Dr Carol Sinnott’s work focuses on medication management in patients with multimorbidity, and the development of interventions to improve the quality of care in general practice. Carol graduated from medical school at University College Cork Ireland and completed higher training on the South East GP Training Scheme, Ireland. She was the first National Academic Research Fellow in General Practice in Ireland, and completed her PhD in the Department of General Practice, University College Cork in 2016. After that, Carol worked Senior Research Fellow on the TRUST randomised control trial in the Department of Epidemiology and Public Health, University College Cork.
Carol has been awarded the Early Career Researcher Award from the Society for Social Medicine UK, the Royal College of General Practitioners’ Sheppard Memorial Prize and the Professor William Shannon Prize for Primary Care Research. She has funded her research with grant awards from the Health Research Board, Irish Research Council and Irish College of General Practitioners.
Additionally, Carol is Specialty Lead for Health Services Research in the Eastern Clinical Research Network. She practices as a GP in Cambridge two days a week.
Multimorbidity, Polypharmacy, Decision-making in General Practice, Behaviour Change Interventions for Health Care Professionals, Implementation Science
Stott DJ, Rodondi N, Kearney PM, Ford I, Westendorp RGJ, Mooijaart SP, Sattar N, Aubert CE, Aujesky D, Bauer DC, Sinnott C et al: Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. N Engl J Med. 2017 Apr 3. [Epub ahead of print]
Riordan DO, Byrne S, Fleming A, Kearney PM, Galvin R, Sinnott C. GPs’ perspectives on prescribing for older people in primary care: a qualitative study. Br J Clin Pharmacol. 2017 Jan 10.
Sinnott C, Byrne M, Bradley CP. Improving medication management for patients with multimorbidity in primary care: a qualitative feasibility study of the MY COMRADE implementation intervention. Pilot Feasibility Stud. 2017 Mar 20;3:14.
Walsh E, Foley T, Sinnott C, Boyle S, Smithson WH. Developing and piloting a resource for training assessors in use of the Mini-CEX (mini clinical evaluation exercise). Educ Prim Care. 2017 Jan 23:1-3.
Riordan DO, Walsh KA, Galvin R, Sinnott C, Kearney PM, Byrne S. The effect of pharmacist-led interventions in optimising prescribing in older adults in primary care: A systematic review. SAGE Open Med. 2016 Jun 14;4:2050312116652568.
Sinnott C, Mercer SW, Payne RA, Duerden M, Bradley CP, Byrne M. Improving medication management in multimorbidity: development of the MultimorbiditY COllaborative Medication Review And DEcision Making (MY COMRADE) intervention using the Behaviour Change Wheel. Implement Sci. 2015 Sep 24;10:132.
Sinnott C, Mc Hugh S, Fitzgerald AP, Bradley CP, Kearney PM. Psychosocial complexity in multimorbidity: the legacy of adverse childhood experiences. Fam Pract. 2015 Jun;32(3):269-75.
Sinnott C, Hugh SM, Boyce MB, Bradley CP. What to give the patient who has everything? A qualitative study of prescribing for multimorbidity in primary care. Br J Gen Pract. 2015 Mar;65(632):e184-91.
Sinnott C, Mc Hugh S, Browne J, Bradley C. GPs’ perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research. BMJ Open. 2013 Sep 13;3(9):e003610.
Sinnott C, Quigley F, Morris M. Promoting exercise in patients with depression: lessons learned from a brief educational intervention. Eur J Gen Pract. 2014 Mar;20(1):32-5.
Sinnott C, Morris M. Agomelatine: clinical experience and adherence to EMA recommendations for a novel antidepressant. Ir Med J. 2013 Feb;106(2):52-4.
McQuillan RF, O’Seaghdha CM, Bagatto A, Manusamy M, Errakiah N, Sinnott C, O’Kelly P, Murphy GM, Conlon PJ. The effect of switching from calcineurin inhibitor to sirolimus on the incidence of skin cancers in kidney transplant recipients. J Eur Acad Dermatol Venereol. 2009 Mar;23(3):330-1.
Stack J, McLaughlin P, Sinnot C, et al. Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone. Scand J Rheumatol. Aug 2010;39(4):349-350.